New topical medications in the treatment of glaucoma.
1. Latanoprost is not preferred for use in inflammatory glaucoma. 2. Brimonidine acts by reducing the aqueous inflow and promotes uveoscleral outflow. 3. Dorzolamide causes a moderate reduction of intraocular pressure, but is relatively safe.
Gandham
S B
SB
Lions Eye Institute, Albany Medical College, NY 12208, USA.
D000287:Administration, Topical; D000959:Antihypertensive Agents / Q000008:administration & dosage*; D000068438:Brimonidine Tartrate; D005901:Glaucoma / Q000188:drug therapy*; D006801:Humans; D000077338:Latanoprost; D011461:Prostaglandins F, Synthetic / Q000008:administration & dosage*; D011810:Quinoxalines / Q000008:administration & dosage*; D013449:Sulfonamides / Q000008:administration & dosage*; D013876:Thiophenes / Q000008:administration & dosage*
D000959:Antihypertensive Agents; D011461:Prostaglandins F, Synthetic; D011810:Quinoxalines; D013449:Sulfonamides; D013876:Thiophenes; D000068438:Brimonidine Tartrate; D000077338:Latanoprost; C062765:dorzolamide